Category: Johnson & Johnson
Johnson & Johnson's DePuy Synthes subsidiary pairs its SIGMA HP partial knee with Blue Belt Technologies' Navio robot-assisted surgical system.
Media reports in India claim that some of medtech's biggest companies are looking the other way when their Indian distributors hike prices and bribe doctors to use their drug-eluting stents.
Some of medtech's biggest players are getting a beating in the Indian media, where reports this week accused them of turning a blind eye to unethical behavior from their distributors in the country.
The plaintiff's lawyer in the 1st product liability trial over DePuy's Pinnacle hip replacement grills another Johnson & Johnson executive, worldwide clinical research vice president Pamela Plouhar, the at DePuy, over the metal-on-metal implants.
Johnson & Johnson subsidiary Cordis Corp. takes its Incraft stent graft system to Europe and Canada for treatment of patients with infrarenal abdominal aortic aneurysms.
Johnson & Johnson (NYSE:JNJ) subsidiary Cordis is taking its Incraft AAA stent abroad after winning regulatory approvals to market the device in Europe and Canada.
Innovative AAA device offers new, less invasive option for patients and physicians.
Here's a look at some of the top legal news stories for medical device companies this week: Ex-ArthroCare CEO Baker draws 20 years; Smith & Nephew settles whistleblower lawsuit for $8M; Secant Medical escapes pelvic mesh cases; Bellwether trial kicks off for DePuy's Pinnacle hip implant; J&J, Boston Scientific, others can't shake Philly pelvic mesh mass tort
, Boston Scientific
, C.R. Bard
, Dept. of Justice (DOJ)
, DePuy Synthes
, Endo Health
, Ethicon Inc.
, Johnson & Johnson
, Secant Medical
, Smith & Nephew
, U.S. Veterans Affairs Dept. (VA)
, American Medical Systems Holdings Inc.
A federal court finds Johnson & Johnson's Ethicon subsidiary guilty of selling a defective transvaginal implant and of failing to warn patients about the device's risks.
Johnson & Johnson's (NYSE:JNJ) Ethicon subsidiary has vowed to file an appeal after a federal jury found the company guilty of selling defective medical devices.